Latest Nasal EPAP Stories
Sleep physicians to gain insights on Inspire therapy at Sleep Medicine Trends and at the 21st Annual Advances in Diagnosis and Treatment of Sleep Apnea and Snoring MINNEAPOLIS, Feb.
Theravent, a non-invasive solution to stop snoring has reached an incredible milestone with more than 2 million quiet nights of sleep for snorers and bed partners alike. SAN
THN3 Study Will Expand the Clinical Evidence for this Novel Neurostimulation Therapy for Moderate to Severe Obstructive Sleep Apnea SAN DIEGO, Nov.
Nierman Practice Management and Sleep Apnea MD have just launched their new service, OSA Referral Network Builder, to dentists across the country who want to build a strong referral network to
Latest research presented at 2014 American Academy of Otolaryngology Meeting in Orlando Sept. 19-23 MINNEAPOLIS and ORLANDO, Fla., Sept.
A new study shows a strong association between severe, untreated obstructive sleep apnea and the risk of elevated blood pressure despite the use of high blood pressure medications.
Theravent® Advanced Nightly Snore Therapy, a clinically proven therapy to reduce or eliminate snoring, proudly announces two new snoring therapies.
A new study with more than 8,500 Canadian patients revealed a link between obstructive sleep apnea (OSA) and the onset of diabetes. The study was the largest one of its kind to date and the results confirmed what earlier studies revealed with smaller and shorter follow-up periods.
Cases of obstructive sleep apnea are multiplying due to sedentary lifestyles and irregular sleep habits LONDON, June 4, 2014 /PRNewswire/ -- The increasingly sedentary lifestyle and
Theravent, Inc., a medical device company providing noninvasive solutions to help people stop snoring recently hit a milestone by exceeding 1 million nights of snoring treatment.